SB-705498 is an investigational drug.
There have been 9 clinical trials for SB-705498.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 26th 2007.
The most common disease conditions in clinical trials are Rhinitis, Toothache, and Cough. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].